Retina

Latest News

Beacon Therapeutics reports positive phase 2 results for gene therapy in X-linked retinitis pigmentosa
Beacon Therapeutics reports positive phase 2 results for gene therapy in X-linked retinitis pigmentosa

September 9th 2025

In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and DAWN patients at month 9 or longer.

Positive topline data announced from AVONELLE-X and SALWEEN trials
Positive topline data announced from AVONELLE-X and SALWEEN trials

September 9th 2025

Q&A: Amir Kashani on biomarkers for Alzheimer disease
Q&A: Amir Kashani on biomarkers for Alzheimer disease

September 8th 2025

Contivue port delivery platform for nAMD receives CE mark
Contivue port delivery platform for nAMD receives CE mark

September 4th 2025

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
EyePod podcast: Innovation Series: How DMEI residents are shaping the future with smartphone imaging for retinal care (part 2)
EyePod podcast: DMEI residents Jibran Sharieff, MD, and Brandon Kingrey, MD, share their journey to innovation (part 1)
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches
Ehsan Sadri, MD,  leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.